购物车
- 全部删除
- 您的购物车当前为空
JSH-0009 dimaleate (Compound 1) 作为一种CDK9抑制剂,显示出显著效能,其IC50仅为0.928 nM。此外,JSH-0009在小鼠体内对皮下肿瘤(急性髓性白血病 MV4-11)的生长也具有有效的抑制作用。
JSH-0009 dimaleate (Compound 1) 作为一种CDK9抑制剂,显示出显著效能,其IC50仅为0.928 nM。此外,JSH-0009在小鼠体内对皮下肿瘤(急性髓性白血病 MV4-11)的生长也具有有效的抑制作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | JSH-0009 dimaleate (Compound 1), a potent CDK9 inhibitor, exhibits an IC50 of 0.928 nM. This compound demonstrably inhibits the growth of subcutaneous tumor (cute myelogenous leukemia MV4-11) in mice . |
靶点活性 | CDK9/cyclinT1:0.928 nM, CDK1/cyclinB:5410 nM, CDK2/cyclinA:6850 nM, CDK3/cyclin E1:>10,000 nM, Cdk5/p25:6950 nM, CDK7/Cyclin H/MNAT1:3700 nM, CDK8/cyclin C:>10,000 nM |
分子量 | 751.25 |
分子式 | C33H43ClN6O10S |
CAS No. | 2559759-04-3 |
存储 | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容